Compare GIC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIC | OGN |
|---|---|---|
| Founded | 1949 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 1996 | 2020 |
| Metric | GIC | OGN |
|---|---|---|
| Price | $39.60 | $13.76 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $11.40 |
| AVG Volume (30 Days) | 119.1K | ★ 2.7M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.44% | 0.60% |
| EPS Growth | ★ 17.09 | N/A |
| EPS | ★ 1.38 | 0.95 |
| Revenue | $1,379,100,000.00 | ★ $6,216,000,000.00 |
| Revenue This Year | $5.72 | $0.45 |
| Revenue Next Year | $4.60 | $1.67 |
| P/E Ratio | $28.71 | ★ $14.48 |
| Revenue Growth | ★ 4.80 | N/A |
| 52 Week Low | $26.40 | $5.69 |
| 52 Week High | $40.71 | $13.77 |
| Indicator | GIC | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 68.34 | 73.31 |
| Support Level | $38.16 | $13.46 |
| Resistance Level | $40.71 | N/A |
| Average True Range (ATR) | 0.89 | 0.04 |
| MACD | -0.12 | -0.00 |
| Stochastic Oscillator | 62.72 | 96.87 |
Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw material.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.